Abstracts

Search by keyword or author name.

Showing 744 abstracts.

Functionality and Determinants of Antibody Responses to H1N1 pandemic Inactivated Vaccine (pH1N1 vaccine) in HIV-Infected Children, Adolescents and Youth

Conference

IDWeek 2013

Study

P1088

Omitting NRTIs from ARV regimens is not inferior to adding NRTIs in treatment experienced HIV+ subjects failing a PI regimen: The ACTG OPTIONS study

Conference

20th Conference on Retroviruses and Opportunistic Infections

Study

A5241

Absent HIV-Specific Immune Responses and Replication-Competent HIV- Reservoirs in Perinatally-Infected Youth treated from Infancy: Towards Cure

Conference

20th Conference on Retroviruses and Opportunistic Infections

Functional HIV Cure after Very Early Antiretroviral Therapy of an Infected Infant.

Conference

20th Conference on Retroviruses and Opportunistic Infections

24 and 48 Week Results from IMPAACT P1066: Raltegravir (RAL) Granules for Suspension (GFS) Formulation in Infants 4 Weeks (wks) to 6 Months (mos) of age

Conference

20th Conference on Retroviruses and Opportunistic Infections

Study

P1066

Efficacy and safety of 6 months versus 6 weeks extended nevirapine (NVP) for prevention of postnatal HIV-1 transmission (PMTCT): 18 month follow-up of the HPTN 046 randomized double blind placebo controlled trial.

Conference

20th Conference on Retroviruses and Opportunistic Infections

Severe immunodeficiency in children starting ART in low-, middle- and high-income countries

Conference

20th Conference on Retroviruses and Opportunistic Infections

Microarray analysis reveals novel insights into immunity to H1N1/09 influenza vaccine in HIV infected children and adolescents in IMPAACT protocol 1088

Conference

20th Conference on Retroviruses and Opportunistic Infections

Study

P1088

Higher Regulatory B and T Cell Rates Are Associated with Decreased Immune Responses to pH1N1 Influenza Vaccine in HIV-Infected Children and Youth

Conference

20th Conference on Retroviruses and Opportunistic Infections

Study

P1088

Pharmacokinetics of Lopinavir/ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines: Interim Results from IMPAACT P1083

Conference

20th Conference on Retroviruses and Opportunistic Infections

Study

P1083